• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-018
Device Problem Migration or Expulsion of Device (1395)
Patient Problem Embolism (1829)
Event Date 01/04/2020
Event Type  Injury  
Manufacturer Narrative
An event of embolization of the 18mm occluder with subsequent implant of a larger, 24mm device was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.Based on the information received, the device was potentially undersized; however, the extent to which this contributed to the subsequent embolization could not be conclusively determined.Information from the field indicated that the device was removed 1 month after embolization.Please note, per the instructions for use artmt100116885 rev.A, "embolized devices must be removed because they may cause patient harm.Embolized devices should not be withdrawn through intracardiac structures unless they have been collapsed within a sheath.".
 
Event Description
On (b)(6) 2020, an 18 mm amplatzer septal occluder was implanted.The following day, the device embolized to the left atrium.The patient did not present any symptoms.On (b)(6), the physician removed the embolized device percutaneously.On (b)(6), a 24mm amplatzer septal occluder was successfully implanted.The patient is currently stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9783081
MDR Text Key183945610
Report Number2135147-2020-00087
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010151
UDI-Public00811806010151
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 03/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2023
Device Model Number9-ASD-018
Device Catalogue Number9-ASD-018
Device Lot Number6837013
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/04/2020
Initial Date FDA Received03/03/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/31/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age47 YR
-
-